Larvol Delta - CHMP-Recommends-EU-Approval-of-New-Indication-for-Alfasigmas-Jyseleca-filgotinib-Treatment-of-Adults-With-Axial-Spondyloarthritis

Jyseleca (filgotinib) - Gilead

https://www.businesswire.com/news/home/20260915829420/en/CHMP-Recommends-EU-Approval-of-New-Indication-for-Alfasigmas-Jyseleca-filgotinib-Treatment-of-Adults-With-Axial-Spondyloarthritis

Sep 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next